Adenovirus COVID-19 Vaccines: Challenges of Prior AD Immunity

Article

Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the messenger RNA candidates to the adenovirus vaccines.

Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the messenger RNA candidates to the adenovirus vaccines.

Dr. Soon-Shiong delves into some of his reasoning for the ImmunityBio vaccine candidate's particular orientation toward the immune system.

Newsletter

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Subscribe Now!
Recent Videos
Related Content
In People With Cancer, COVID-19 Vaccine Boosters Reduce Hospitalizations

In People With Cancer, COVID-19 Vaccine Boosters Reduce Hospitalizations

John Parkinson
July 17th 2025
Article
Tailoring Therapies in Community Acquired Pneumonia in the Inpatient Setting

Tailoring Therapies in Community Acquired Pneumonia in the Inpatient Setting

George Sakoulas, MD
November 6th 2023
Podcast
Danish Study Reinforces Safety of Childhood Vaccines with Aluminum Adjuvants

Danish Study Reinforces Safety of Childhood Vaccines with Aluminum Adjuvants

Sophia Abene
July 16th 2025
Article
ACIP Preferentially Recommends Fluzone High-Dose Influenza Vaccine for Seniors

ACIP Preferentially Recommends Fluzone High-Dose Influenza Vaccine for Seniors

Nina Cosdon
June 23rd 2022
Podcast
FDA Approves Moderna’s COVID-19 Vaccine For Children Aged 6 Months Through 11 Years

FDA Approves Moderna’s COVID-19 Vaccine For Children Aged 6 Months Through 11 Years

John Parkinson
July 11th 2025
Article
Early Detection of COVID-19 Infection? There's Possibly an App for That

Early Detection of COVID-19 Infection? There's Possibly an App for That

Kenneth Bender, PharmD, MA
July 9th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.